These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24043726)
1. Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors. Kim MK; Warner RR; Roayaie S; Harpaz N; Ward SC; Itzkowitz S; Wisnivesky JP J Clin Oncol; 2013 Oct; 31(30):3776-81. PubMed ID: 24043726 [TBL] [Abstract][Full Text] [Related]
2. The Lymph Node Ratio Optimizes Staging in Patients with Small Intestinal Neuroendocrine Tumors. Wu L; Chen F; Chen S; Wang L Neuroendocrinology; 2018; 107(3):209-217. PubMed ID: 29920478 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors. Kim MK; Warner RR; Ward SC; Harpaz N; Roayaie S; Schwartz ME; Itzkowitz S; Wisnivesky J Neuroendocrinology; 2015; 101(1):58-65. PubMed ID: 25572143 [TBL] [Abstract][Full Text] [Related]
4. Prognostic validity of the American Joint Committee on Cancer staging classification for midgut neuroendocrine tumors. Strosberg JR; Weber JM; Feldman M; Coppola D; Meredith K; Kvols LK J Clin Oncol; 2013 Feb; 31(4):420-5. PubMed ID: 23248248 [TBL] [Abstract][Full Text] [Related]
5. Prognostic Role of Lymph Node Positivity and Number of Lymph Nodes Needed for Accurately Staging Small-Bowel Neuroendocrine Tumors. Zaidi MY; Lopez-Aguiar AG; Dillhoff M; Beal E; Poultsides G; Makris E; Rocha F; Crown A; Idrees K; Marincola Smith P; Nathan H; Beems M; Abbott D; Barrett JR; Fields RC; Davidson J; Cardona K; Maithel SK JAMA Surg; 2019 Feb; 154(2):134-140. PubMed ID: 30383112 [TBL] [Abstract][Full Text] [Related]
6. Improving survival prognostication of gastroenteropancreatic neuroendocrine neoplasms: Revised staging criteria. Martin JA; Warner RR; Wisnivesky JP; Kim MK Eur J Cancer; 2017 May; 76():197-204. PubMed ID: 28334622 [TBL] [Abstract][Full Text] [Related]
7. Prognostic Performance of Different Lymph Node Staging Systems in Patients With Small Bowel Neuroendocrine Tumors. Jiang S; Zhao L; Xie C; Su H; Yan Y Front Endocrinol (Lausanne); 2020; 11():402. PubMed ID: 32733379 [No Abstract] [Full Text] [Related]
8. Mesenteric Tumor Deposits in Midgut Small Intestinal Neuroendocrine Tumors Are a Stronger Indicator Than Lymph Node Metastasis for Liver Metastasis and Poor Prognosis. Fata CR; Gonzalez RS; Liu E; Cates JM; Shi C Am J Surg Pathol; 2017 Jan; 41(1):128-133. PubMed ID: 27684993 [TBL] [Abstract][Full Text] [Related]
9. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival. Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279 [TBL] [Abstract][Full Text] [Related]
10. Lymph Node Metastasis in the Prognosis of Gastroenteropancreatic Neuroendocrine Tumors. Martin JA; Warner RRP; Aronson A; Wisnivesky JP; Kim MK Pancreas; 2017 Oct; 46(9):1214-1218. PubMed ID: 28902794 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs. Chen L; Zhou L; Zhang M; Shang L; Zhang P; Wang W; Fang C; Li J; Xu T; Tan H; Zhang P; Qiu M; Yu X; Jin K; Chen Y; Chen H; Lin R; Zhang Q; Shen L; Chen M; Li J; Li L; Chen J BMC Cancer; 2017 Aug; 17(1):521. PubMed ID: 28778195 [TBL] [Abstract][Full Text] [Related]
12. Predictors of lymph node metastasis and survival in radically resected rectal neuroendocrine tumors: A Surveillance, Epidemiology, and End Results (SEER) database analysis. Emile SH; Horesh N; Garoufalia Z; Gefen R; Wignakumar A; Wexner SD Surgery; 2024 Sep; 176(3):668-675. PubMed ID: 38918107 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of Pathologic Prognostic Factors in Neuroendocrine Tumors of the Small Intestine. Polydorides AD; Liu Q Am J Surg Pathol; 2022 Apr; 46(4):547-556. PubMed ID: 35192293 [TBL] [Abstract][Full Text] [Related]
14. Association of a Prophylactic Surgical Approach to Stage IV Small Intestinal Neuroendocrine Tumors With Survival. Daskalakis K; Karakatsanis A; Hessman O; Stuart HC; Welin S; Tiensuu Janson E; Öberg K; Hellman P; Norlén O; Stålberg P JAMA Oncol; 2018 Feb; 4(2):183-189. PubMed ID: 29049611 [TBL] [Abstract][Full Text] [Related]
15. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International Collaboration on Oropharyngeal cancer Network for Staging (ICON-S): a multicentre cohort study. O'Sullivan B; Huang SH; Su J; Garden AS; Sturgis EM; Dahlstrom K; Lee N; Riaz N; Pei X; Koyfman SA; Adelstein D; Burkey BB; Friborg J; Kristensen CA; Gothelf AB; Hoebers F; Kremer B; Speel EJ; Bowles DW; Raben D; Karam SD; Yu E; Xu W Lancet Oncol; 2016 Apr; 17(4):440-451. PubMed ID: 26936027 [TBL] [Abstract][Full Text] [Related]
16. Toll-like receptors 1-9 in small bowel neuroendocrine tumors-Clinical significance and prognosis. Hiltunen N; Kemi N; Väyrynen JP; Böhm J; Kauppila JH; Huhta H; Helminen O PLoS One; 2024; 19(5):e0302813. PubMed ID: 38709790 [TBL] [Abstract][Full Text] [Related]
17. Colon Neuroendocrine Tumors: A New Lymph Node Staging Classification. Fields AC; McCarty JC; Lu P; Vierra BM; Pak LM; Irani J; Goldberg JE; Bleday R; Chan J; Melnitchouk N Ann Surg Oncol; 2019 Jul; 26(7):2028-2036. PubMed ID: 30927196 [TBL] [Abstract][Full Text] [Related]
18. A Lymph Node Ratio-Based Staging Model Is Superior to the Current Staging System for Pancreatic Neuroendocrine Tumors. Gaitanidis A; Patel D; Nilubol N; Tirosh A; Kebebew E J Clin Endocrinol Metab; 2018 Jan; 103(1):187-195. PubMed ID: 29069375 [TBL] [Abstract][Full Text] [Related]
19. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital. Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699 [TBL] [Abstract][Full Text] [Related]
20. TNM staging of neoplasms of the endocrine pancreas: results from a large international cohort study. Rindi G; Falconi M; Klersy C; Albarello L; Boninsegna L; Buchler MW; Capella C; Caplin M; Couvelard A; Doglioni C; Delle Fave G; Fischer L; Fusai G; de Herder WW; Jann H; Komminoth P; de Krijger RR; La Rosa S; Luong TV; Pape U; Perren A; Ruszniewski P; Scarpa A; Schmitt A; Solcia E; Wiedenmann B J Natl Cancer Inst; 2012 May; 104(10):764-77. PubMed ID: 22525418 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]